Primary Site >> Colorectal Cancer
Gene >> CYP19A1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [The chemoradiotherapy of advanced colorectal carcinoma--the results and toxicity in a pilot study with 44 patients]. PMID: 8451725 |
Ref: [Adjuvant and neoadjuvant therapy of rectal carcinoma. The current status]. PMID: 9810316 |
Ref: Loss of estrogen inactivation in colonic cancer. PMID: 10372714 Ref: Estrogen synthesis in human colon cancer epithelial cells. PMID: 10704911 |
Ref: Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). PMID: 11370551 Ref: [Simultaneous radiochemotherapy in rectal tumors]. PMID: 11975410 |
Ref: Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. PMID: 11872273 Ref: Mammalian phytoestrogens: enterodiol and enterolactone. PMID: 12270221 Ref: The underlying basis for obesity: relationship to cancer. PMID: 12421869 |
Ref: Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. PMID: 12925071 Ref: P27 does not predict histopathological response to radiochemotherapy in rectal cancer. PMID: 12957127 Ref: Cyclooxygenase-2 and chemoprevention of breast cancer. PMID: 14623549 |
Ref: [Present treatment strategies for rectal carcinoma]. PMID: 15739059 Ref: Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. PMID: 15774776 Ref: Potential use of COX-2-aromatase inhibitor combinations in breast cancer. PMID: 16100520 Ref: [Revolution of certain adjuvant treatments and role of anti-aromatase agents in postmenopausal breast cancer. Adjuvant treatment of colorectal cancer. New treatments for kidney and pancreatic cancers]. PMID: 16117051 Ref: Ten polymorphisms of estrogen-metabolizing genes and a family history of colon cancer--an association study of multiple gene-gene interactions. PMID: 16202920 Ref: Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. PMID: 16246976 |
Ref: Role of radiotherapy with surgery for T3 and resectable T4 rectal cancer: evidence from randomized trials. PMID: 16456638 Ref: Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials. PMID: 16730086 Ref: Alternative clinical end points in rectal cancer--are we getting closer? PMID: 16873440 Ref: Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy. PMID: 16943523 Ref: Should preoperative or postoperative therapy be administered in the management of rectal cancer? PMID: 17178291 Ref: Aromatase inhibitors: structural features and biochemical characterization. PMID: 17261771 |
Ref: Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94. PMID: 17197130 Ref: In vitro evaluation of human cytochrome P450 and P-glycoprotein-mediated metabolism of some phytochemicals in extracts and formulations of African potato. PMID: 17336049 Ref: Integration of novel agents into combined-modality treatment for rectal cancer patients. PMID: 17497093 Ref: Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk. PMID: 17615053 Ref: Radiation therapy in stage II and III rectal cancer. PMID: 18006798 Ref: Preoperative chemoradiotherapy in the management of localized rectal cancer: the new standard. PMID: 19262719 Ref: Adjuvant chemoradiation for localized rectal cancer: current trends and future directions. PMID: 19360151 |
Ref: Polyaspartylhydrazide copolymer-based supramolecular vesicular aggregates as delivery devices for anticancer drugs. PMID: 18307306 Ref: Fractionation of polyphenol-enriched apple juice extracts to identify constituents with cancer chemopreventive potential. PMID: 18398871 Ref: BRAF silencing by short hairpin RNA or chemical blockade by PLX4032 leads to different responses in melanoma and thyroid carcinoma cells. PMID: 18458053 Ref: Multidisciplinary management of resectable rectal cancer. New developments and controversies. PMID: 19086601 |
Ref: The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. PMID: 19128956 Ref: Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors. PMID: 19141651 Ref: [Individualizing treatment for locally advanced rectal cancer]. PMID: 19350305 Ref: Preoperative chemoradiotherapy in locally advanced rectal cancer: correlation of a gene expression-based response signature with recurrence. PMID: 19380020 Ref: Limitation of surgical radicality in rectal cancer responding to neoadjuvant therapy. PMID: 19420978 Ref: Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery. PMID: 19672927 |
Ref: Preoperative chemoradiotherapy does not necessarily reduce lymph node retrieval in rectal cancer specimens--results from a prospective evaluation with extensive pathological work-up. PMID: 19830503 Ref: [Rectal cancer and adjuvant chemotherapy: which conclusions?]. PMID: 19965305 Ref: Genetic variation in sex-steroid receptors and synthesizing enzymes and colorectal cancer risk in women. PMID: 20148360 |
Ref: Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy. PMID: 20473860 Ref: Variation in the CYP19A1 gene and risk of colon and rectal cancer. PMID: 21479914 Ref: Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial. PMID: 21555684 Ref: Estrogen and progesterone-related gene variants and colorectal cancer risk in women. PMID: 21627810 Ref: Decreased expression of 17beta-hydroxysteroid dehydrogenase type 1 is associated with DNA hypermethylation in colorectal cancer located in the proximal colon. PMID: 22176788 |
Ref: CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer. PMID: 22001634 Ref: Effect of butyrate on aromatase cytochrome P450 levels in HT29, DLD-1 and LoVo colon cancer cells. PMID: 22386365 Ref: Rectal cancer: state of the art in 2012. PMID: 22450150 Ref: Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. PMID: 22529255 Ref: Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. PMID: 22627104 Ref: Farnesoid X Receptor (FXR) from normal to malignant state. PMID: 22648540 Ref: Aromatase in colon carcinoma. PMID: 22843875 Ref: The aromatase gene (CYP19A1) variants and circulating hepatocyte growth factor in postmenopausal women. PMID: 22848710 Ref: [Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin in rectal cancer: initial results of the CAO/ARO/AIO-04 study]. PMID: 23089949 Ref: The effect of the combined action of roscovitine and Paclitaxel on the apoptotic and cell cycle regulatory mechanisms in colon and anaplastic thyroid cancer cells. PMID: 25969761 |
Ref: Multidisciplinary approach to rectal cancer: are we ready for selective treatment strategies? PMID: 23272969 Ref: Oestrogen and colorectal cancer: mechanisms and controversies. PMID: 23319136 Ref: Obesity and inflammation: new insights into breast cancer development and progression. PMID: 23714453 Ref: Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: long-term results of the German CAO/ARO/AIO-94 phase III trial. PMID: 23768685 Ref: Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement. PMID: 23851331 |
Ref: Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial. PMID: 24752056 Ref: CYP19A1 single nucleotide polymorphism associations with CYP19A1, NFkappaB1, and IL6 gene expression in human normal colon and normal liver samples. PMID: 25114581 Ref: Neoadjuvant chemoradiotherapy for locally advanced rectal cancer: The debate continues. PMID: 25516776 |
Ref: Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: the reverse of the Will Rogers phenomenon? PMID: 25611452 Ref: Estrogen and cancers of the colorectum, breast, and lung in postmenopausal women. PMID: 26126901 Ref: Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. PMID: 26189067 |
Ref: Identification of Predictive Markers for Response to Neoadjuvant Chemoradiation in Rectal Carcinomas by Proteomic Isotope Coded Protein Label (ICPL) Analysis. PMID: 26861291 Ref: Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup. PMID: 27050599 Ref: [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?]. PMID: 27106241 Ref: Advances in management of adjuvant chemotherapy in rectal cancer: Consequences for clinical practice. PMID: 27156922 Ref: Rectal cancer: Neoadjuvant chemoradiotherapy. PMID: 27644910 Ref: Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies. PMID: 27752113 Ref: New arylated benzo[h]quinolines induce anti-cancer activity by oxidative stress-mediated DNA damage. PMID: 27922047 |
Ref: Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. PMID: 28759385 Ref: CYP19A1 gene polymorphism and colorectal cancer etiology in Saudi population: case-control study. PMID: 29066910 Ref: Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer. PMID: 29206996 Ref: Analysis of 12 variants in the development of gastric and colorectal cancers. PMID: 29358861 |
Ref: Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial. PMID: 29718095 Ref: Long-term prognostic impact of surgical complications in the German Rectal Cancer Trial CAO/ARO/AIO-94. PMID: 29846017 Ref: Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trial. PMID: 29873684 Ref: Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial. PMID: 29874375 Ref: Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials. PMID: 29929861 Ref: Cost analysis of a wait-and-see strategy after radiochemotherapy in distal rectal cancer. PMID: 29987338 Ref: Cost-utility analysis of 5-fluorouracil and capecitabine for adjuvant treatment in locally advanced rectal cancer. PMID: 29998007 |